Due to the small number of As2O3 treatment cases in clinical therapy, primary mononuclear leukemia cells positive for P-gp expression were cultured from nine AML patients and analyzed for changes in MDR1 expression following treatment with As2O3. This evidence concerns the gene ABCB1 and leukemia.